⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
prnewswire.com
LLY
Remedy Meds GLP-1 Weight Loss 2026: Pricing, the FDA Compounding Shakeup, and What to Know Before You Commit to a Monthly Plan
accessnewswire.com
LLY
NVO
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players
globenewswire.com
AMGN
BMY
LLY
JNJ
PFE
MRK
ZWS
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
prnewswire.com
LLY
MEDVi Claims Evaluated: Most Affordable Tirzepatide GLP-1 Weight Loss Clinic Online — 2026 Search Trends and Publicly Available Pricing Information Context
globenewswire.com
LLY
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts
globenewswire.com
GILD
LLY
AMGN
MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results
globenewswire.com
MGTX
LLY
T. ROWE PRICE EXPLORES LEADERSHIP, TRANSFORMATION, AND THE FUTURE OF MOBILITY WITH FORD CEO JIM FARLEY
prnewswire.com
TROW
F
GE
NYT
ISRG
NVDA
XOM
CRH
LLY
TMUS
Power and Paradox: Value of Leading US Brands Rises to $6.44 Trillion as Global Trust Weakens
businesswire.com
AAPL
MSFT
GOOGL
GOOG
HBAN
BAH
LLY
BEN